Form D · Other Investment Fund

GMO TRUST ON BEHALF OF ITS SERIES GMO U.S. FLEXIBLE EQUITIES FUND

Boston, MA · CIK 0001544481

Offering snapshot reported Mar 15, 2013 · SEC filing

Reported sold
$6.63B
Indefinite offering
Investors reported
32
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.32B$6.63BAug 1, 2012: $6,630,953,169.00Aug 1, 2012Mar 15, 2013: $6,630,953,169.00Mar 15, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2013Amendment$6,630,953,169$0vs Aug 1, 201232SEC filing
Aug 1, 2012Initial$6,630,953,169No comparison32SEC filing

Offering details

Securities
Other
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-182082
SHARES

Source: Form D, filed Mar 15, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Braverman Director
Sheppard N. Burnett Executive
Donald W. Glazer Director
Joseph B. Kittredge Executive
Peter Tufano Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
40 Rowes Wharf
Boston, MA, 02110